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Abstract
Introduction The tau statistic is a recent second-order correlation func-
tion that can assess the magnitude and range of global spatiotemporal clus-
tering from epidemiological data containing geolocations of individual cases
and, usually, disease onset times. This is the first review of its use, and
the aspects of its computation and presentation that could affect inferences
drawn and bias estimates of the statistic.
Methods Using Google Scholar we searched papers or preprints that
cited the papers that first defined/reformed the statistic. We tabulated their
key characteristics to understand the statistic’s development since 2012.
Results Only half of the 16 studies found were considered to be using
true tau statistics, but their inclusion in the review still provided important
insights into their analysis motivations. All papers that used graphical hy-
pothesis testing and parameter estimation used incorrect methods. There
is a lack of clarity over how to choose the time-relatedness interval to relate
cases and the distance band set, that are both required to calculate the statis-
tic. Some studies demonstrated nuanced applications of the tau statistic in
settings with unusual data or time relation variables, which enriched under-
standing of its possibilities. A gap was noticed in the estimators available to
account for variable person–time at risk.
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Discussion Our review comprehensively covers current uses of the tau
statistic for descriptive analysis, graphical hypothesis testing, and parameter
estimation of spatiotemporal clustering. We also define a new estimator of
the tau statistic for disease rates. For the tau statistic there are still open
questions on its implementation which we hope this review inspires others to
research.
Keywords: dependence, second-order, spacetime clustering, transmission,
relative risk, global statistic
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1. Introduction
Transmission of infection is a dynamic process in time and space. In-
fectious diseases spread because a pathogen is transmitted by ‘contact’ with
‘parent’ cases (where we use ‘contact’ in a loose sense to include transmission
from the parent case(s) via a vector, airborne transmission, fomites, environ-
mental contamination etc.). It is therefore expected that observed cases are
infected by a parent case both close in time and space. The additional dis-
tinction of a spatiotemporal infection process is because normally any case
will only be infectious for a short period relative to the study length thus
leaving a temporal signal coinciding with their spatial presence. We focus on
infectious diseases which require some explicit consideration of the infection
process to formulate pair-relatedness variables. However, the risk factors for
non-infectious diseases like poverty, environment, family/cultural traits may
also follow spatiotemporal processes, like those between parent and offspring
cases which we seek to measure for infectious disease. This demonstrates how
non-infectious risk factors that coincide with infectious transmission may in-
terfere with the spatiotemporal signal measured from an infectious disease
dataset.
Knox defines clustering as “a geographically bounded group of occur-
rences of sufficient size and concentration to be unlikely to have occurred by
chance” [1]. This could be ‘hotspot clustering’ which is “any area within the
study region of significant elevated risk” [2], or global clustering which is a
general tendency to cluster across a study. We avoid using the term ‘spa-
tial/spatiotemporal dependence’ as it is not clearly defined in the literature.
Increasing availability of accurate geolocation data in recent years has
enabled better understanding of this process. Being able to detect global
disease clustering and assess its spatial extent can inform decisions on in-
fectious disease control that can make better use of limited public health
resources. However, standard clustering statistics in this domain often con-
sider the spatial dimension only. (§1.1). Here we review publications using
the tau statistic [3, 4]—a recent global clustering statistic for infectious dis-
ease (§2). In this literature review we explain its general purpose and identify
sources of bias in the statistic. In an upcoming paper we consider how the
different aspects of implementation identified here may bias the tau statistic
[5].
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1.1. Current statistics & tests for global clustering
This review focuses on the tau statistic [3, 4], but we first present other
statistics for assessing disease clustering to highlight the benefits of the tau
statistic to newcomers. Ward summarises spatiotemporal methods for disease
data [6] by those that are based on mechanistic modelling, like spatiotem-
poral kernel models [7], and those based on statistical modelling, like the
Mate´rn cluster process that describes a spatiotemporal point process; where
statistics may be chosen for computational efficiency or the assumptions and
sensitivities of the spatial distributions of the underlying population at risk
[6]. Alternatively, empirical measures can estimate global clustering of in-
dividual cases (first-order) (§1.1) or case pairs (second-order) (§1.1 & §2).
Second-order measures are particularly appropriate for investigating the in-
fection process between individuals since we typically assume that infection
occurs from one parent case infecting one susceptible offspring.
1.1.1. Spatial-only or spatiotemporal tests
Cuzick & Edwards’ k-nearest neighbours test [8], Anderson & Tittering-
ton’s Integrated Squared Difference function [9] and Tango’s C [10] are tests
for clustering that divide the data into cases and controls. Unfortunately
they only describe clustering in the spatial dimension. These three tests
assume “two independent inhomogeneous Poisson processes with spatially-
varying intensities: m1(x) for sampled cases and m2(x) for sampled controls”
[10] randomly chosen from “individuals at risk in the study region” [10].
Cuzick & Edwards’ k-nearest neighbours test sums the number of case-case
pairings within a certain range [8], which has similarities to the tau statistic.
Tk :=
∑
i
∑
j
aijδiδj, where δi = 1(i is a case), and for locations xj of case j
aij = 1(xj ∈ k-nearest neighbours of xi)
(1)
Anderson & Titterington’s Integrated Squared Difference function ( ÎSD) smooths
the difference of non-parametric kernel density-estimated relative risks in
cases and controls (mˆ1, mˆ2) at point x across 2D space S [9, 10].
ÎSD :=
∫
x∈S
(mˆ1(x)− mˆ2(x))2dx (2)
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Tango’s C imposes a parametric kernel in the ÎSD (Equation 2), e.g. a step
function for hotspot clusters or exponential decay for clinal clusters [10].
Spatiotemporal K-function initially developed for stationary point processes
[11], it has strong connections to the tau statistic as it is mentioned in ap-
pendix of the first paper to define and use the tau statistic [3], hereafter
referred to as the Root paper. Epidemiologically, its stationarity will never
adequately explain a disease process and a constant intensity does not take
account of population heterogeneity. Gabriel & Diggle’s inhomogeneous K
function extended it using a special class of inhomogeneous point processes
[12] and is available through the stpp R package [13]. It requires a spatial
case intensity estimate via kernel-based density estimation and a temporal
estimate from time-series modelling [12] so the calculation can be lengthy.
* * *
The tau statistic is defined in section 2 and the review into its use described
in section 3. We identify best practices, determine aspects of its estimation
where it may be biased and make recommendations in sections 4 & 5.
7
2. The tau statistic
2.1. A brief history
The tau statistic1 is a non-parametric global clustering statistic which
evaluates the disease frequency (risk, odds or rate) within a certain annulus
around an average case and compares it to the background measure (at any
distance), so is always positive [3, 4]. “It measures the tendency of case
pairs to spatially cluster while implicitly accounting for their likeliness of
being transmission-related temporally, making it a spatiotemporal statistic”
[5, 3, 4]. Occasionally, space and time are swapped to measure temporal
clustering instead with transmission relations based on spatial proximity.
The tau statistic was first defined and applied in 2012 by Salje et al. [3].
In 2016 Lessler et al. described its context in the fields of spatial statistics and
epidemiology, demonstrated robustness, formulated estimators for case-only
or case & non-case data, and reformed formulae in the Tau paper [4]. Both
these foundation papers have inspired a steady stream of papers applying
the tau statistic or similar statistics. The code to calculate both τˆodds, τˆprev
estimators is available in the IDSpatialStats R package [15]. Since datasets
with thousands of cases can take tens of hours to construct confidence inter-
vals for, we have re-implemented τˆodds & τˆprev in the C language, providing
a speed-up of up to 76 times [16]. For a dataset of a few hundred cases the
point estimate and bootstrapped tau estimates can typically be obtained in
seconds.
There are some similarities between the tau statistic and earlier statis-
tics which focused on areas of excess risk R: R(x) = λ(x)/g(x) where the
numerator represented the case intensity at point x in space S and denomi-
nator the “background effect” [17]. “Some information concerning the scale
of clustering can also be obtained by this method” [18] on changing tolerance
bounds to detect where clustering is strongest. The tau statistic’s functional
form differs as the numerator’s distance band [d1, d2) is nested within the
denominator’s (0,∞) as we shall see in Equations 3-5.
1This tau statistic is different from ‘Kendall’s tau statistic’ or ‘Kendall’s rank correla-
tion coefficient’ which is a bivariate statistic for ordinal data [14].
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2.2. Tau statistic τodds (odds ratio estimator)
The distance form of the tau statistic τodds is a ratio of the odds θ(d1, d2)
of finding any case j which is related to any case i, within a half-closed2
annulus [d1, d2) around case i, versus the odds θ(0,∞) of finding related
cases over any distance separation (dij ≥ 0) for N total cases
τˆodds(d1, d2) :=
θˆ(d1, d2)
θˆ(0,∞)
where θˆ(d1, d2) =
∑N
i=1
∑N
j=1,j 6=i 1(zij = 1, d1 ≤ dij < d2)∑N
i=1
∑N
j=1,j 6=i 1(zij = 0, d1 ≤ dij < d2)
,
(3)
where 1 represents the indicator function, i.e. is equal to 1 when its argu-
ment(s) are all true and 0 otherwise. It is best described as “equivalent
to ratios of multitype pair correlation functions” [4]. Values of τ > 1 sig-
nify spatiotemporal clustering, τ = 1 implies no clustering/inhibition and
0 < τ < 1 means inhibition. The odds θˆ in Equation 3 is the ratio of the
number of related case pairs within [d1, d2) to the number of unrelated case
pairs. The relatedness of a case pair zij is determined using temporal (close
onset times ti, tj), serological (same serotypes) or genotype information (e.g.
most recent common ancestor within a time difference of the earliest onset
of the pair [19]) [4]. “Typically temporal relation is defined when case onset
times are within a single serial interval of each other” [5]. This relatedness
is a probable but not certain statement of direct transmission; still the tau
statistic is able to recover a spatiotemporal signal in many of its applications.
Sometimes an expanding disc is chosen so we set d1 = 0, relabel d = d2 and
have τ(d) instead. τodds is similar to an odds ratio in that it is a ‘ratio of
odds’ yet note how the numerator’s distance condition (d1 ≤ dij < d2) is a
subset of the denominator (∀dij ≥ 0), whereas traditionally an odds ratio is
between two mutually exclusive conditions.
2.3. Tau statistic τprev (relative prevalence estimator)
With the additional data of non-case locations one can compute the preva-
lence pˆi(d1, d2) of related case pairs within a certain annulus versus any case
2This corrects Lessler et al.’s appendices [4] that originally used an open interval. “It
has been updated in their GitHub repository [15] following email communication on 6
December 2018” [5]
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or non-case pairing, and thus the prevalence form of the tau statistic ap-
proximates a risk of onset [4]. The tau statistic then becomes the relative
prevalence of related case pairs within an annulus versus at any distance from
an average case i (Equation 4). Note that N now represents the number of
cases and non-cases combined.
τˆprev(d1, d2) :=
pˆi(d1, d2)
pˆi(0,∞)
where pˆi(d1, d2) =
∑N
i=1
∑N
j=1,j 6=i 1(zij = 1, d1 ≤ dij < d2)∑N
i=1
∑N
j=1,j 6=i 1(d1 ≤ dij < d2)
(4)
2.4. A new tau statistic τrate (rate ratio estimator)
2.4.1. Motivation
Closed populations are an unrealistic model of nature due to migration,
births and deaths. For long studies it is inaccurate to consider all participants
being exposed to infection risk for equal times. Epidemiologists take account
of this varying time-at-risk through a rate statistic. Furthermore, for diseases
that confer little immunity and so occur repeatedly in the same individual,
the true burden of disease would be underestimated if only one case per
person is counted. For example, in cholera epidemics in Bangladesh [20], O1
& O139 strains co-circulate yet infection from either does not confer cross-
protection [21].
2.4.2. The estimator
A rate ratio estimator of the tau statistic τrate can be calculated for data
consisting of cases and non-cases, with time-varying geolocations, study en-
try and exit times and onset and recovery times for each disease episode
(Equation 5).
τrate(d1, d2) :=
λ(d1, d2)
λ(0,∞) (5)
From first principles, the incidence rate λ is traditionally defined as the num-
ber of new events divided by the person–time-at-risk [22]. For this second-
order statistic we counted not the onset of a case but the transmission event
across pairs. Individual i is allowed to have zero to multiple disease episodes.
Each single episode l for individual i will result in multiple probable pair
episodes (l → m), each of which are linked to the multiple episodes m of a
particular individual j within [d1, d2) of i and within a certain time differ-
ence (tm − tl). So for nr people at risk with n total disease episodes during
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the study period, λ is described by summing episodes in the numerator and
person–time-at-risk in the denominator, unlike τodds & τprev which sum cases
or cases & non-cases, respectively (Equation 6).
λ(d1, d2) =
∑n
l=1
∑n
m=1,kl 6=km 1(zlm = 1, d1 ≤ dlm < d2)∑nr
i=1
∑nr
j=1,j 6=i
∑Tend
t=1 1(Zij(t) = 1, d1 ≤ dij(t) < d2)
(6)
where Zij(t) = 1(([inf. starti, inf. endi]∩[susc. startj, susc. endj]∩[t]) 6= {φ})
and kl(= i), km(= j) denote the indices of the individual to which the
episodes belong; the denominator describes the total pair time at risk and
is the length of time each i, j pair could be potentially relatable in space
and time; [inf. starti, inf. endi] represents the infectious period of individual
i while [susc. startj, susc. endj] represents j’s period of susceptibility, given
the immunising effects of previous infection (if appropriate) and time spent
in different locations xj(t) relative to other i’s (Fig. 1).
Of course for a self-immunising disease, a pair will only share one episode
at most; τrate is still useful in this instance as different pair times at risk still
need to be accounted for. Note that the alternate calculation of i’s person–
time-at-risk due to j is not symmetric. This means τrate will take longer
to compute than τodds or τprev as we cannot assume transmission pairs are
undirected. A proof of concept for a real-world dataset with large migratory
movements is needed to see if τrate provides a substantially different estimate
to τprev or τodds in terms of τ(d) and the range of spatiotemporal clustering
[0, D].
2.5. Statistical characteristics
Lessler et al. have found the following through epidemic simulations [4]:
• The range of clustering is consistent whether computed from the rela-
tive prevalence τprev or odds ratio τodds estimators.
• Only one temporal, serotype or genotype relatedness metric is needed
to infer related pairs. However more metrics will better identify true
transmission pairs so that the range of clustering will less resemble the
area of elevated prevalence and more the area of elevated risk, thus
reducing the range of clustering and increasing the magnitude of τ in
this region.
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• In addition to the K function that estimates the clustering range, the
tau statistic gives the relative magnitude of disease risk, odds or rate
versus the background; this could provide informative priors for later
mechanistic Bayesian modelling.
• It is robust to population spatial heterogeneities: correctly identifies no
clustering in a spatially-clustered population unlike the pair correlation
function. It consistently estimates the range of clustering when only
a random 1% of cases are observed or if there is spatial observation
bias e.g. around a surveillance outpost. This is because it is “robust
to heterogeneities in sampling probability over a study area, as the
probability of sampling will similarly affect both the numerator and
the denominator” [4].
• Diseases with an effective reproductive number (“the average number
of people someone infected at time t can infect over their infectious
lifespan” [23]) Re > 1 will overestimate the clustering range while un-
derestimating the magnitude of the τ in the true region of clustering.
• Edge corrections are unnecessary.
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3. Methods
3.1. Search strategy, selection & data extraction
We collected publicly-available works on 10 January 2019 that have cited
the Root or Tau paper including articles (full text or abstract), conference
abstracts, books, preprints, theses and dissertations in any language. We
used Google Scholar to find articles (referred to as set B) that cite set A
(either the Root paper [3] or Tau paper [4]); excluding duplicates. We also
looked for articles that cited set B, called set C: in case set C only referred
to the closest paper of inspiration from set B rather than set A. We checked
active forks from GitHub repositories of the IDSpatialStats package [24,
15]. We also searched google.com for webpages and blogs about the “tau
statistic”, with disambiguation exclusions. We also announced our review to
some of the previous paper authors (Salje, Lessler, Truelove & Cummings)
to inquire about any work in their research groups which was soon due for
submission. We only accepted those which actively used the statistic in
their analyses; mere citations to mention a previous clustering result for that
particular disease were disregarded.
The remaining works were then read fully and we contacted the papers’
corresponding authors to clarify missing information; furthermore, follow-
ing manuscript submission to arXiv, we gave them a ‘right-to-reply’ on 1
December 2019 to our commentary on their papers. This is some of the
metadata extracted to summarise and find similarities, and ensure reviewing
consistency:
• Disease
• Format of work (article, preprint, report etc)
• Country & setting
• Study type (cohort, cross-sectional, etc.)
• Sampling method for the data
• Calculation method of the tau statistic
• How they presented results of the tau statistic in text & graphics
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This review is restricted to the use of the tau statistic, as consistently de-
scribed in the Root & Tau papers only. Although we found papers which
claimed but did not in fact use the tau statistic, this is not a critique of their
analyses. We still considered papers claiming to use the tau statistic because
we wanted to review a broad spectrum of analyses based on the authors’
belief that it was a tau analysis, which is still relevant to this review.
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4. Results
4.0.1. Source information
For works already online prior to journal publication we recorded its later
journal version in the bibliography. Google Scholar found 16 papers (includ-
ing the Root & Tau papers) [3, 4, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35,
36, 37, 19] that claimed to use the tau statistic in their analyses (Table 3);
61 papers that mentioned the Root and 6 the Tau paper without using the
statistic were ignored. There was no active code, webpages nor blogs about
the statistic. All were peer-reviewed articles or reports except one recent
preprint [36]; all peer-reviewed works were from respected journals with a
minimum recent impact factor of 2·8. The Root paper was published in June
2012 and 15 separate works followed in 2014(2 )3; 2015(1 ); 2016(5 ); 2017(1 );
2018(5 ) & 2019(1 ) (Table 3:col. 1). The Tau paper published in May 2016
saw 10 papers follow it. There were seven that cited both the Root & Tau
papers [31, 32, 33, 34, 35, 36, 30] and a further seven that cited the Root
only [37, 19, 25, 26, 27, 28, 29]. All papers had multiple authors and always
involved Salje and/or Lessler.
4.0.2. Statistic purpose
The main use was determining clustering and its strength but two novel
alternatives were: calibrating an Approximate Bayesian Computation model
by adding τ as summary statistic that captured global clustering [33]; and
empirically as a stopping criterion once a random labelling algorithm had
reached a certain global clustering threshold [31] (Table 3:col. 5).
4.0.3. Disease spectrum & study location
The papers covered seven human diseases—chikungunya, cholera, HIV,
influenza/influenza-like illnesses/upper respiratory illnesses, measles, pneu-
monia, and dengue which made the most appearances(8 ) (Table 3:col. 2).
Analyses cover all populated continents except South America and Oceania.
The tau statistic or related statistics has been used in settings where the
region is a substantial landmass [31] or where there were spatial restrictions
nearby or through their populations due to rivers [32, 33, 34, 3, 36, 19, 28, 29],
walkways [37] or major roads [27] (Table 3:col. 3).
3Italicised numbers in round brackets indicate the number of papers.
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4.0.4. Study length, region size & spatial/temporal resolution
The tau statistic is most commonly used in cohort studies, which ranged
from 3 months to 5 years with median 15·5 months (Table 3:col. 6). Two
studies used cross-sectional data.
The spatial resolution of field studies was often constrained by GPS re-
ceivers i.e. ∼ 10m (Table 3:col. 6). When relying on patient’s reported street
address to extract a geolocation, large spatial errors of 110m-1km were calcu-
lated when validated with a household visit [3, 34]. Furthermore cases may
be aggregated at a higher spatial level because of gridded population data
[33] or too few cases during the study period [29]. The temporal resolution
in days, weeks or months was ultimately constrained by the reporting sys-
tem. For tau papers which explicitly reported it, temporal resolution was as
follows: cholera 1 day(2 ); dengue 1 day(1 ), 1 month(2 ); measles 1 day(1 ).
One paper used data with a temporal resolution similar to the length of
the serial interval [34] (Table 2) which is not ideal: as it could miss additional
transmission pairs (i→ j and j → k) as conceivably within the mean 15-17
day incubation period, a case i may infect j and it infect a secondary case
k, yet at monthly resolution only i→ k would be observed.
4.0.5. Tau statistic estimators & bootstrapping
We consider only eight of the 16 papers that claimed to use the tau
statistic actually used the form defined in the foundation papers [3, 4] (Table
3:col. 4). Not all papers used the same estimators as τodds, τprev defined in
the founds ratio estimator for case-only data (Equation 3) was the most
common because studies typically collect the geolocation of only cases; the
distance form appears in three of the 16 papers reviewed [32, 33, 34] with
the lesser-known time form in two [32, 35].
The prevalence estimator (Equation 4) appeared in three papers [3, 26,
30]. Despite odds ratios and risk ratios not being mathematically equivalent
and some papers using the term ‘risk’ generically for all disease measures, at
low prevalences of ∼ 1% they are effectively equal [38].
The rate estimator τrate we defined in §5 is yet to be used. We found
one application of a rate-style risk ratio that varied with distance [37]. The
choice of a rate made sense as the epidemiological unit was respiratory ill-
ness events—something a person could have repeatedly. However they did
not explicitly account for variable times at risk, presumably because they
assumed that all participants stayed throughout the study.
The time form τ(t1, t2) swaps space and time and defines case pairs as
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related if they are within a specific distance band around a case. It is then
evaluated across a set of time bands. Using a panel plot for different dis-
tance windows helps map out a “dynamic risk zone” [32] akin to a simpler
representation of the 2D spacetime tau colour map [3]. We still consider this
a tau statistic as spatiotemporal information is retained, just presented in a
different way.
The number of bootstrap samples chosen had a wide range: 100(2 ),
500(6 ), 1000(4 ), 10,000(1 ) or unknown(2 ).
4.0.6. Case definitions & misclassification
In most situations the case definitions were of a clinical standard beyond
those typically employed for surveillance (Table 3:col. 4). For diseases with a
particularly fast progression from onset-to-death like cholera, people may die
before reaching the hospital thus causing the data to be left-censored. There
may be misclassification if the case definition of say cholera (acute watery
diarrhoea at any age [21]) shares signs or symptoms with other pathogens
like E.coli, shigella etc. Consideration is needed if the planned control is
expected to prevent these related pathogens too and thus overestimate the
potential reduction in the magnitude of tau at close distances. Finally it
is unclear how the statistic would perform for an unknown disease with a
broadly defined case definition e.g. in the initial stages of an epidemic.
There is potential misclassification of probably-related pairs if other con-
tact activities occur by a different process than described by case dwelling
proximity [37]. For instance in Levy et al. (a study of respiratory illness in
military recruits) considered bed location in sleeping quarters as the spatial
unit that would describe the infection process whereas activities like attend-
ing a crowded mess hall could be opportunities for infection.
The example of Grabowski et al. [26] challenges the assumption that using
a more recent marker of infection (i.e. incident rather than prevalent HIV)
will better identify probable transmission pairs thus leading to a stronger tau
signal. The likely explanation for prevalent-incident case pairings showing
higher relative risk within the household than incident-incident pairs is likely
due to the low per act risk of HIV-1 infection for heterosexual vaginal sex in
a developing country setting (0·08% [39]) and given the relatively short study
(18 months) it would have been more likely to receive reports of prevalent-
incident case pairs than incident-incident.
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4.0.7. Graphical presentation
• The general use of two continuous lines to represent the upper and
lower parts of a series of pointwise confidence intervals is unhelpful to
the untrained reader. Instead plotting each point estimate with its own
confidence bands like Salje et al. [30] encourages the reader to consider
each in turn. However since this is a common reader mistake, a default
warning in the caption may be required too.
• Most tau papers use a τ -versus-distance graph (and one τ -versus-time
[32]) to show the magnitude of τ varying with distance.
• The convention is to plot τ(d1, d2) at the midpoint of the distance band
like in Lessler et al. [4] i.e. d =½(d1 + d2), but may be misinterpreted
if not explained in the caption. The ideal default would plot the end
of the distance band instead, unless the graph is used for parameter
estimation purposes and then the midpoint makes sense.
• For within-household transmission the spatial aspect of the infection
process is no longer modelled as household members have no spatial
freedom to move as their house is modelled as a point. It may therefore
be misleading to plot a line joining [d = 0, τ(d = 0)] ↔ [d2nd , τ(d2nd)]
unless the first distance band includes non-zero distances i.e. d ≥ 0.
• Plotting the tau axis on a log scale can aid identification of the curve’s
structure. However a log scale for the distance axis may affect accurate
τˆ(d) = 0 determination.
• All point estimates should include envelopes unless multiple point es-
timates are displayed.
• Some plot too many tau lines on the same graph [32, 28]. This is
discouraged for more than three envelopes—aligned panel plots are an
alternative.
• The graph should cover the full extent of both bounds of the confidence
interval. The axes’ lines should meet at the origin so that the reader
can easily read off values. The horizontal line for τ = 1 is always
helpful.
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• The figure caption should note the tau estimator, envelope type, num-
ber of bootstrap samples [40] and definition for time relatedness: since
the graph’s shape is dependent on these values.
• The Root paper ([3]:Fig. 3) offers an advanced 2D colour plot where
each pixel represents the tau estimate for a given distance and time
lag. For diagnostic purposes this would be appropriate for a disease of
an unknown aetiology where a diagnostic plot for initial explanatory
analysis is required because the serial interval is approximate. As well
as the spatiotemporal signal of primary transmission, it can reveal sea-
sonality (through repeated regular patterns in the temporal axis) and
the immunising effect of each serotype [3]. However like spatiotemporal
variograms the number of pairs that are separated by long spatial or
temporal lags reduces, requiring caution near the plot’s extremities.
4.0.8. Distance band choice
The distance from an average case i can be represented by a half-closed
annulus with distance band [d1, d2) or as an open disc [d1 = 0, d2). The
choice depends on the purpose of analysis. An annulus will give a more pre-
cise estimate closer to some ‘instantaneous’ τ , but conversely as narrower
distance bands contain fewer pairs, τ will become more variable and lead to
a τ -versus-distance graph that is spikier with an indiscernible trend. Alter-
natively an open disc conveys the cumulative risk up to a said distance d2
for use by policymakers: it represents how fieldworkers operate i.e. up to a
fixed distance from an index case [0, d2), rather than a complicated annu-
lus shape. However open discs also smooth any intermediary spatiotemporal
structure like village-to-village. Smoothing can be accentuated further by
allowing distance bands to overlap as at least three papers do [4, 32, 31]4.
Also as d2 increases, annuli will cover more pairs so that the estimate’s vari-
ance changes with distance which is detrimental to the performance of global
envelope tests [41] (a method that will soon be employed for graphical hy-
pothesis testing in [5]). Setting bins with equal numbers of pairs may solve
this.
The tau statistic may in theory be definable at a specific single distance
lag and time lag from a case to describe an instantaneous relative measure
of risk, however it could never be estimated for a real data set as we only
4we learned of this for [4] through their analysis code that they kindly shared with us
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have a finite collection of points in spacetime, and apart from household
transmission (d = 0), a given space◦time lag combination is likely to exist
for one pair at most. We therefore have to settle for distance bands. This
thought experiment demonstrates how the existence of a true tau statistic is
not known unless a future statistical proof can show asymptotic convergence
to a particular limit as the number of points tend to infinity or a distance
band width tends to zero. It is also telling that even if we know the trans-
mission tree the estimate is still dependent on the distance bands we choose.
Minimisation of the mean squared error ((τˆ − τ)2 + Var(τˆ)) is tempting but
even the ‘true’ τ is dependent on the set of distance bands. In conclusion
this highlights a problem for internal validity, as for the same dataset we can
arrive at a non-unique tau estimate.
4.0.9. Variables used to define relatedness
‘Location & time’ are the common variables(5 ) used to identify probable-
related transmission pairs (Tables 1 & 3:col. 4).
frequency
tau studies non-tau studies
location+
case time∗ 3 4
case time & serotype 4 0
case time, serotype, MRCA∗∗ time 0 1
serostatus or none 1 3
Table 1: Epidemiological variables used in the papers’ statistics to describe transmission-
relatedness of pairs. *presentation, admission or onset time of the case. **most recent
common ancestor.
Some authors purported use of a ‘tau statistic’ lacked a temporal element
[31] thus reducing it to a spatial statistic. Either the papers used the phi
statistic φ (a related statistic concerned with spatiotemporal interaction [3])
[29, 25, 36], or risk [37, 28, 19, 31] or odds ratios [27]. For instance, for pi(d)
(the numerator of τprev) Levy et al. used the probability of finding sick pairs
within distance d out of all sick pairs, rather than the probability that pairs
found within d are sick, while their denominator for τ was the proportion
of pairs within d rather than the proportion of sick pairs with d compared
to all pairs. Similarly others make τ the ratio between seroconverted and
all individuals [28, 19] or cases and non-cases [27] rather than between the
risk/odds of finding a case within a distance versus at all distances.
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Grabowski et al. [26] is a unique example of the tau statistic where no
temporal, geno nor serotype information is needed to link pairs—through
an implicit temporal relation. Since a prevalent case is defined as having
HIV before the study, and incident cases are those detected during the 19
month study, a temporal relation between prevalent and incident cases can be
formed. This may be a useful workaround if explicit onset data is unavailable
for your study. All authors use case or virus pairs to represent the transmis-
sion chain, except Grantz et al. [25] who use death pairings; but this limits
what can be inferred about transmission: the distribution of deaths is the
convolution of the transmission process (of interest to us) with the infection-
to-death process, where the latter would be confounded by local poverty and
access to healthcare. However practically deaths may be the only available
variable from the initial assessment of an outbreak of an unknown cause.
4.0.10. Defining time-relatedness using serial intervals
The aim is to represent pairs involved in primary transmission i.e. a single,
direct transmission event between parent case i and offspring case j so it has
been common to choose a time-relatedness interval with length equal to a
single serial interval (Table 3:col. 4). We compare the time intervals chosen
against published serial intervals (Table 2). Conceptually there is sufficient
reason to believe τ is sensitive to the choice of the [ti = T1, tj = T2] interval,
but if so then to what extent and how to find the ‘optimal’ [T1, T2]? It is
not solely about maximising specificity as for some diseases, altering T1, T2
to minimise co-primary and secondary transmission, may result in nothing
left of the primary transmission peak. Alternatively a poor choice could
contaminate the primary transmission signal with other indirectly-related
transmission chains like coprimaries or the primary cases k of j. Additionally
we do not yet know how the effect of transmission contamination biases the
true spatiotemporal signal of primary transmission.
It is common for studies to use a particular interval without reference to
the source, except Azman et al.’s cholera study [32]. As a caution to future
tau statistic users, the reliability of published incubation period parameters
is poor e.g. a sample of respiratory viral infections found half did not cite the
source [42]. It is not just the length of the interval that is of interest but the
start and endpoints (T1, T2) too—papers commonly use T1 = 0 and set T2 to
the mean serial interval (Table 2).
Azman et al. [32] are nuanced in their [T1, T2] selection for intepretative
purposes. Initially they chose [0, 5d]—sensible as cholera can have an incu-
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bation period as short as a few hours [21]. However they switch to [1, 5d] to
show the elevated risk in cases that they could avert i.e. it is unrealistic to be
expected to respond to the reported onset of case i, to mitigate a same-day
onset of j.
Disease Serial interval chosen Published source
Cholera
[0, 5d](2 )
[0, 4d](1 )
[1, 4d](1 )
[0, 5d],. . . ,[25d, 30d](1 )
median 5d, range 1-11d [43, 44]
Dengue
Same month [0, 0mo](1 )
[1, 3mo](1 )
[3, 4-30mo](1 )
mean 15-17d [45]
Measles [0, 2wk](1 ) mean 11·7d [46], 14·9d [47]
Table 2: Serial intervals featuring in reviewed articles (paper frequencies in round brackets)
compared with values from published sources. Papers choosing variable times [30] or
model-informed times [35] have been excluded.
4.0.11. Testing spatiotemporal clustering & estimating its range
It is common for authors to test the evidence against no spatiotempo-
ral clustering using visual inspection of a τ -versus-distance graph, which is
a graphical hypothesis test. As detailed in [5], all papers incorrectly esti-
mated this range in two ways and incorrectly simultaneously established the
significance of clustering:
i) most construct bootstrapped estimates around the point estimate to
form a central envelope with a particular upper and lower bound accord-
ing to a series of pointwise confidence intervals; they chose the endpoint
of the clustering range as where the lower bound of the central envelope
touched τ = 1.
ii) one paper [3] randomly permuted the time marks t across all cases (with
points (x, y, t)) to simulate a process with no spatiotemporal clustering.
An envelope was constructed about these simulations that straddled
τ = 1 to form a null envelope to simulate H0 : τ = 1; where the point
estimate touches the upper bound marks the endpoint. Again the upper
and lower bounds are defined by a series of pointwise confidence intervals.
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In [5], we propose corrections for the hypothesis test of no clustering
H0 : (τ = 1) using global envelope tests [48] and estimation of the range
of clustering as the horizontal set of points where the bootstrapped simula-
tions τˆ ∗ intersect τ = 1intersection points where the bootstrapped simulation
τˆ ∗(d) = 1 (as kindly suggested by Peter Diggle in a Skype conversation on
22 October 2019). The latter also provides a measure of precision for the
clustering range, unavailable under the existing methods.
In essence the methods of the reviewed papers are incorrect as they:
• mix graphical hypothesis testing (which can only give a binary answer
of accept/reject no spatiotemporal clustering i.e. H0 : τ = 1) with
parameter estimation. Nearly all authors determine the range when
the lower bound of the confidence interval touches 95%. Azman et al.
[32] takes account of the uncertainty in the range of spatiotemporal
clustering by requiring that the lower confidence bound has crossed
unity over two consecutive distance bands or the median distance when
bootstrap samples fall below 1·2. However this is arbitrary as we do
not have a theoretically-informed correction factor.
• Pointwise confidence intervals are common to describe the uncertainty
in τˆ however many authors [3, 26, 4, 34, 32] incorrectly use them for
hypothesis testing to assert “statistically significant” [3, 26] results: it is
incorrect to scan the graph and search at multiple points along d where
the bound of τ or null envelope is first crossed and then declare that
as the clustering endpoint. Since multiple pointwise CIs are compared
with τ = 1, during this inspection it amounts to a series of multiple
hypothesis tests which inflates the chance a true null hypothesis is
rejected (type I error).
• Their method also cannot estimate the uncertainty of the clustering
range parameter D estimated.
All papers use two-sided confidence intervals. This is sensible as im-
munising effects could cause inhibition at close distances. Although for a
well-studied disease with known localised clustering, there may be reason to
choose a one-tailed test apriori.
4.0.12. External validity
The tau statistic has been well tested in a range of infectious diseases
exploring person-to-person and vector transmitted diseases, with short to
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medium serial intervals and different markers of case relatedness (Table
3:cols. 2 & 4). The study settings have ranged from urban, peri-urban to
rural setting at different population densities (Table 3:col. 3).
The tau statistic has not yet been applied to diseases like leprosy or vis-
ceral leishmaniasis whose highly variable incubation periods would increase
the uncertainty in the clustering range [21].
5. Discussion
Clustering is an important characteristic to shed light on infection dy-
namics and can inform disease control or academic study. The tau statistic
has been applied for this purpose to disease datasets which contain the lo-
cation of cases (and possibly non-cases) and some variables to link probable
transmission pairs by temporal, serological or genotypic attributes.
This review surveyed a number of papers which claimed to analyse disease
clustering using the tau statistic. We only considered half of the 16 papers
reviewed to truly use the tau statistic as originally defined by the foundation
papers [3, 4]; this was either because a temporal element was lacking or their
formulae were better described as a risk/odds ratio or phi statistic. Lessler
et al.’s analysis demonstrated robustness of the statistic Lessler et al. [4].
However, we caution readers that they cannot necessarily expect these same
benefits or caveats to apply for statistics outside the τodds or τrisk definition.
Despite this, this review has been richer for their inclusion through learning
about the authors’ analysis motivations. This review has also uncovered
examples of good practice or ways in which the statistic has been redefined:
• defining the lower interval T1 of the time-relatedness interval [T1, T2]
to equal the expected field response time to avoid overestimating the
elevated risk that may be averted
• outcome variable of death rather than case of disease
• plotting a ‘distance lag’-vs-‘time lag’ 2D colour plot, where each pixel
represents a tau value
• a time form of the tau statistic τ(t1, t2)
• considering ‘pre-study’ (prevalent) cases and ‘during study’ (incident)
cases as a proxy to define time-relatedness on if onset times are un-
available
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Knowledge about the tau statistic has been concentrated in the medium
of journal articles and further limited to papers written by authors of the
foundation papers—Salje & Lessler. Yet this statistic could be very useful
to infectious disease modellers, field epidemiologists and policy makers, par-
ticularly given its implementation in the freely available IDSpatialStats R
package. To further boost adoption, we plan to provide R Markdown tutorials
of the tau statistic on open access training hubs like RECONlearn.org.
We hope this review has given readers an appreciation of the tau statistic
with caveats on its use. Like any statistic the skilled epidemiologist should
still be aware of standard concepts like case definitions to avoid misclassifi-
cation. On graphing the results we have mentioned a few standard practices
that can present the data objectively to avoid misleading the reader. De-
pending on the graphical purpose of the τ -vs-distance graph, open annuli
for control policy questions; or open discs to investigate fine spatiotemporal
structure may be appropriate, respectively. Furthermore as a spatiotemporal
statistic one must consider the data’s spatial resolution, temporal resolution
relative to the mean serial interval, and if the space and time variables are
likely to represent the actual infection process.
5.1. Recommendations for further quantitative research
Following this review we recommend the following aspects of the tau
statistic’s implementation are further investigated to assess their bias:
• It is currently unclear how best to choose the distance band set to
reduce both bias and variance in the tau statistic and whether equi-
distant or equi-number bins should compose them.
• If using time-relatedness to link cases then how to choose the interval
[T1, T2] given a known serial interval for the disease.
• Differences in health status or treatment-seeking/healthcare could change
the disease latent period or infectious period, respectively. Would this
require a reappraisal of the time-relatedness interval over the course of
the study?
• The number of bootstrap samples ranges over 100 fold but the impor-
tance of this implementation parameter is unknown.
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• Test the new rate ratio estimator τrate on a dataset containing geolo-
cations of cases and non-cases and the times of onset and recovery of
disease episodes. The chosen setting should be where individuals have
variable times-at-risk of disease due to seasonal migration or staggered
study entry/exit; ideally the disease would be one that confers little
protection following exposure so that multiple episodes are observable.
Assess differences in the estimator compared to τprev. Given the scarcity
of existing good quality data of this kind, a study may to be prospec-
tively designed.
• Investigate the use of the tau statistic as a (global) spatial summary
statistic for Approximate Bayesian Computation. To what extent does
the tau statistic help with computation accuracy and efficiency and
how should it be weighted relative to other summary statistics used by
the algorithm?
• Immunity from disease exposure had a large biasing effect on the esti-
mation of the mean transmission distance of simulated epidemics [49].
It is therefore sensible to assess tau statistic performance for immunis-
ing (SIR-style)5 and non-immunising (SIS-style) diseases.
• Test the validity of the tau statistic for diseases with highly variable
incubation periods
• Is the tau statistic prone like other spatial statistics to population shift
bias over time?
• Although it has been shown to robustly extract a clustering signal for
a 1% fraction of a simulated dataset [4], what is the minimum number
of cases for the tau statistic to perform reliably?
• What is the theoretical formulation of the tau statistic and can math-
ematical analysis of its statistical properties bring us new insights?
• Considering that the tau statistic uses symmetric shapes like discs or
annuli that assume an isotropic disease process, how would anisotropies
5SIR is a compartmental model describing the progression of individuals from
Susceptible, through Infected, to Recovered states of a disease. SIS diseases oscillate
between S and I as individuals do not gain protection following infection.
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in transmission e.g. along road networks, land relief or wind affect tau
estimates?
• Impact of spatial aggregation of misspecification versus actual infection
location and seasonality, on the tau statistic.
Some of the above aspects will be covered in an upcoming quantitative study
applied to a measles dataset [5].
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* * *
Control programmes have already been informed by the tau statistic so apply-
ing improvements on its implementation and further research will safeguard
future health decisions based on it.
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10. Figures
study time, t
entryj exitj
entryi exiti
T1 T2 T3 T4
tA tB
Key
inf.
not susc.
susc.
j:
i:
Figure 1: Describing the calculation of the person-time-at-risk (tA + tB) of individual j,
due to i, by accounting for j’s location with respect to i, j’s susceptibility to infection
(which for some diseases may depend on previous exposure) and i’s infectious period. j is
born and enters the study and stays within [d1, d2) of i’s eventual entry. j is considered
to be exposed to risk of i during [T1, T2] as j loses maternal immunity at t = T1, thus
becoming susceptible and is spatiotemporally related to i. At t = T2, j becomes infected
and is no longer susceptible. One potentially-related episode pair i → j is counted. j
recovers but is exposed again to risk from i during [T3, T4] when i becomes infectious
again (in this example previous exposure does not confer protection). j leaves the study,
and does not experience a second episode w.r.t. i (at least not when when enrolled on the
study).
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10.1. Key characteristics of the reviewed papers
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